non glp 1 weight loss drugs A Guide to Weight-Loss Medications: Anti-obesity drugs, from older pills to the new GLP-1s Understanding Weight Loss Medications: GLP-1

Le Gras, S

Therapies currently being considered include antivirals like valganciclovir, a guanosine analog with potent anti-human herpesvirus activity, including in vitro and in vivo activity against the lytic phase of EBV that can reduce mucosal shedding of EBV during treatment (127)

Additionally, future studies should examine whether sulforaphane could address different aspects of age-related impairments in skeletal muscle function, including injury susceptibility, fatigue, and muscle regenerative capacity

[76] [77] activation of TAAR1 may restore impaired dopaminergic signaling in the prefrontal cortex and thereby correct deficits in inhibitory control associated with binge eating behaviors